Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Capricor Therapeutics, Inc.
Capricor Therapeutics Inc is a clinical stage biotechnology company developing products for the treatment of cardiovascular diseases with a focus on heart failure.
IPO Date: March 1, 2007
Sector: Healthcare
Industry: Biotech
Market Cap: $452.51M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.18 | 3.95%
Avg Daily Range (30 D): $0.69 | 6.21%
Avg Daily Range (90 D): $0.64 | 5.86%
Institutional Daily Volume
Avg Daily Volume: .64M
Avg Daily Volume (30 D): 3M
Avg Daily Volume (90 D): 2.3M
Trade Size
Avg Trade Size (Sh.): 186
Avg Trade Size (Sh.) (30 D): 128
Avg Trade Size (Sh.) (90 D): 108
Institutional Trades
Total Inst.Trades: 305
Avg Inst. Trade: $1.36M
Avg Inst. Trade (30 D): $1.07M
Avg Inst. Trade (90 D): $1.14M
Avg Inst. Trade Volume: .12M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.5M
Avg Closing Trade (30 D): $1.23M
Avg Closing Trade (90 D): $1.25M
Avg Closing Volume: 127.31K
   
News
Jul 14, 2025 @ 2:00 PM
INVESTOR ALERT: Pomerantz Law Firm Investigates Cl...
Source: Pomerantz Llp
Jul 11, 2025 @ 5:00 PM
INVESTOR ALERT: Investigation of Capricor Therapeu...
Source: Holzer & Holzer, Llc
Jul 3, 2025 @ 2:00 PM
INVESTOR ALERT: Pomerantz Law Firm Investigates Cl...
Source: Pomerantz Llp
Jun 2, 2025 @ 5:55 PM
INVESTOR ALERT: Pomerantz Law Firm Investigates Cl...
Source: N/A
May 16, 2025 @ 10:36 PM
CAPR Investors Have Opportunity to Join Capricor T...
Source: Business Wire
Financials
  TTM Q4 2024 FY 2024
Basic EPS $-.53 $-.11 $-1.15
Diluted EPS $-.53 $-.11 $-1.15
Revenue $ M $ 11.13M $ 22.27M
Gross Profit $ $ $
Net Income / Loss $ -24.39M $ -7.12M $ -40.47M
Operating Income / Loss $ -24.98M $ -7.7M $ -42.56M
Cost of Revenue $ $ $
Net Cash Flow $ 17.51M $ -57.09M $ -3.41M
PE Ratio    
Splits
Jun 05, 2019:   1:10
Nov 21, 2013:   1:50
Feb 09, 2007:   1:10
Apr 05, 2005:   1:20